SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,239,818 | -11.8% | 3,081,307 | 0.0% | 7.97% | -4.3% |
| Q2 2023 | $80,791,870 | +101764.6% | 3,081,307 | 0.0% | 8.32% | -16.1% |
| Q1 2023 | $79,313 | -36.9% | 3,081,307 | -36.2% | 9.91% | -29.4% |
| Q4 2022 | $125,662 | -99.9% | 4,831,307 | 0.0% | 14.04% | -14.6% |
| Q3 2022 | $137,837,000 | +15.9% | 4,831,307 | 0.0% | 16.45% | +17.9% |
| Q2 2022 | $118,947,000 | -56.4% | 4,831,307 | 0.0% | 13.95% | -47.3% |
| Q1 2022 | $272,679,000 | -8.9% | 4,831,307 | 0.0% | 26.48% | +11.5% |
| Q4 2021 | $299,444,000 | -2.3% | 4,831,307 | 0.0% | 23.75% | +24.9% |
| Q3 2021 | $306,498,000 | -36.2% | 4,831,307 | -17.1% | 19.01% | -39.6% |
| Q2 2021 | $480,558,000 | +12.0% | 5,831,307 | 0.0% | 31.49% | +29.6% |
| Q1 2021 | $429,009,000 | -18.8% | 5,831,307 | -19.9% | 24.30% | -26.7% |
| Q4 2020 | $528,040,000 | +52.1% | 7,281,307 | 0.0% | 33.15% | +2.5% |
| Q3 2020 | $347,100,000 | +13.5% | 7,281,307 | 0.0% | 32.35% | +1.0% |
| Q2 2020 | $305,815,000 | +55.6% | 7,281,307 | 0.0% | 32.03% | -3.7% |
| Q1 2020 | $196,595,000 | -29.9% | 7,281,307 | 0.0% | 33.25% | -20.5% |
| Q4 2019 | $280,258,000 | +77.5% | 7,281,307 | 0.0% | 41.80% | +2.8% |
| Q3 2019 | $157,859,000 | – | 7,281,307 | – | 40.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |